Evidence map›Paper›PMID 30535971›Full record

ReviewPlant foods for human nutrition (Dordrecht, Netherlands)2019

Anticancer Potential of Syzygium Species: a Review.

Lee Kee Chua, Chooi Ling Lim, Anna Pick Kiong Ling, Soi Moi Chye, Rhun Yian Koh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Anticancer acumens of three Annona species: a proportional review.Journal of cancer research and clinical oncology · 2023
    Review
  5. Review
  6. Anticancer of genusExploration of targeted anti-tumor therapy · 2023
    Review
  7. Article
  8. Review
  9. Frontiers in pharmacology · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Therapeutic application of Carica papaya leaf extract in the management of human diseases.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lee Kee ChuaDivision of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Chooi Ling LimDivision of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Anna Pick Kiong LingDivision of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Soi Moi ChyeDivision of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Rhun Yian KohDivision of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia. rhunyian_koh@imu.edu.my.ORCID http://orcid.org/0000-0003-4190-8288

Funding

International Medical University BMSc I/2017(10)
6 · The paper itself

Abstract

Cancer is a preventable and treatable disease, however, the incidence rates are on the rise. Classical treatment modalities for cancer include surgery, radiotherapy and chemotherapy. However, these are associated with detrimental side effects such as nausea and emesis. Therefore, researchers currently vest interest in complementary and alternative medicines for cancer treatment and prevention. Plants such as Syzygium sp. are a common basis of complementary medicines due to its abundance of bioactive phytochemicals. Numerous natural compounds derived from Syzygium sp., such as phenolics, oleanolic acids, and betulinic acids, and dimethyl cardamonins, were reported to have anticancer effects. Many possess the ability to inhibit cell proliferation and induce apoptosis. In this review, we discuss the vast potential Syzygium sp. harbours as a source of anticancer natural compounds due to its abundance, easy acceptability, affordability and safety for regular consumption.

Indexed as

Antineoplastic Agents, PhytogenicBetulinic AcidChalconesHumansOleanolic AcidPentacyclic TriterpenesPhenolsPhytochemicalsPlants, MedicinalSyzygiumTriterpenesAntineoplastic Agents, PhytogenicBetulinic AcidcardamoninChalconesOleanolic AcidPentacyclic TriterpenesPhenolsPhytochemicalsTriterpenesAnticancerBioactive compoundSyzygium species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.